Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K3SM
|
|||
| Former ID |
DIB010765
|
|||
| Drug Name |
MALP-2S
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 1/2 | [1] | |
| Company |
MBiotec GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase ... Br J Cancer. 2007 Sep 3;97(5):598-604. | |||
| REF 2 | Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2. Microbes Infect. 2011 Apr;13(4):350-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.